Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK)
HKD 18.04
(0.33%)
HKD 18.04
(0.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 75.51 Billion | 70.78 Billion | 69.01 Billion | 61.67 Billion | 64.95 Billion | 42.23 Billion |
| Cost of Revenue | 61.32 Billion | 57.51 Billion | 55.78 Billion | 51.23 Billion | 52.08 Billion | 32.16 Billion |
| Gross Profit | 14.18 Billion | 13.27 Billion | 13.23 Billion | 10.44 Billion | 12.87 Billion | 10.06 Billion |
| Operating Expenses | 9.06 Billion | 8.73 Billion | 8.84 Billion | 6.96 Billion | 8.8 Billion | 7.4 Billion |
| Selling, General and Administrative Expenses | 6.7 Billion | 6.42 Billion | 6.43 Billion | 5.03 Billion | 6.94 Billion | 5.6 Billion |
| Research and Development Expenses | 782.14 Million | 819.45 Million | 874.71 Million | 611.93 Million | 576.51 Million | 585.49 Million |
| Other Expenses | -318.04 Million | 1.48 Billion | 1.54 Billion | 1.31 Billion | 1.28 Billion | 298.35 Million |
| Cost and Expenses | 70.39 Billion | 66.24 Billion | 64.63 Billion | 58.19 Billion | 60.88 Billion | 39.57 Billion |
| Operating Income | 5.12 Billion | 5.07 Billion | 4.78 Billion | 3.67 Billion | 4.05 Billion | 3.83 Billion |
| Interest Expense | 446.19 Million | 434.4 Million | 417.83 Million | 363.34 Million | 393.65 Million | 231.57 Million |
| Income Tax Expense | 851.17 Million | 789.87 Million | 754.08 Million | 647.45 Million | 687.24 Million | 485.01 Million |
| Earnings before Tax | 5.11 Billion | 5.04 Billion | 4.72 Billion | 3.73 Billion | 4.12 Billion | 4.01 Billion |
| Net Income | 4.05 Billion | 3.96 Billion | 3.71 Billion | 2.91 Billion | 3.18 Billion | 3.44 Billion |
| Earnings Per Share Basic | 2.49 | 2.44 | 2.29 | 1.79 | 1.96 | 2.12 |
| Earnings Per Share Diluted | 2.49 | 2.44 | 2.29 | 1.79 | 1.96 | 2.12 |
| Weighted Average Shares Outstanding | 1.62 Billion | 1.62 Billion | 1.62 Billion | 1.62 Billion | 1.62 Billion | 1.62 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.62 Billion | 1.62 Billion | 1.62 Billion | 1.62 Billion | 1.62 Billion | 1.62 Billion |
| Gross Margin | 0.19 | 0.19 | 0.19 | 0.17 | 0.20 | 0.24 |
| EBIT Margin | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 | 0.11 |
| Profit Margin | 0.05 | 0.06 | 0.05 | 0.05 | 0.05 | 0.08 |
| EBITDA | 6.48 Billion | 5 Billion | 5.81 Billion | 4.67 Billion | 3.9 Billion | 4.32 Billion |
| Earnings Before Tax Margin | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 | 0.09 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 18.01 Billion | 18.09 Billion | 22.94 Billion | 17.33 Billion | 75.51 Billion | 18.21 Billion |
| Cost of Revenue | 15.35 Billion | 15.37 Billion | 17.86 Billion | 14.81 Billion | 61.32 Billion | 14.86 Billion |
| Gross Profit | 2.65 Billion | 2.71 Billion | 5.07 Billion | 2.51 Billion | 14.18 Billion | 3.34 Billion |
| Operating Expenses | 1.87 Billion | 2.02 Billion | 2.68 Billion | 2.21 Billion | 9.31 Billion | 2.14 Billion |
| Selling, General and Administrative Expenses | 4.34 Billion | 851.04 Million | 2.53 Billion | 229.48 Million | - | 2.94 Billion |
| Research and Development Expenses | 187.36 Million | 205 Million | 186.13 Million | 202.66 Million | - | 178.9 Million |
| Other Expenses | -2.65 Billion | 3.21 Million | 91.02 Thousand | -6.56 Million | -10.39 Million | -47.28 Million |
| Cost and Expenses | 17.23 Billion | 17.4 Billion | 20.54 Billion | 17.02 Billion | 70.64 Billion | 17.01 Billion |
| Operating Income | 774.97 Million | 773.84 Million | 2.45 Billion | 364.63 Million | 5.12 Billion | 1.22 Billion |
| Interest Expense | 104.12 Million | 106.91 Million | 106.43 Million | 113.18 Million | 446.19 Million | 107.55 Million |
| Income Tax Expense | 155.22 Million | 140.75 Million | 420.61 Million | 27.46 Million | 851.17 Million | 212.75 Million |
| Earnings before Tax | 776.63 Million | 777.06 Million | 2.45 Billion | 358.06 Million | 5.11 Billion | 1.21 Billion |
| Net Income | 609.41 Million | 591.44 Million | 1.95 Billion | 264.42 Million | 4.05 Billion | 980 Million |
| Earnings Per Share Basic | 0.41 | 0.39 | 1.20 | 0.16 | - | 0.60 |
| Earnings Per Share Diluted | 0.41 | 0.39 | 1.20 | 0.16 | - | 0.60 |
| Weighted Average Shares Outstanding | 1.62 Billion | 1.62 Billion | 1.62 Billion | 1.62 Billion | 1.62 Billion | 1.62 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.62 Billion | 1.62 Billion | 1.62 Billion | 1.62 Billion | 1.62 Billion | 1.62 Billion |
| Gross Margin | 0.15 | 0.15 | 0.22 | 0.15 | 0.19 | 0.18 |
| EBIT Margin | 0.05 | 0.05 | 0.11 | 0.02 | - | 0.07 |
| Profit Margin | 0.03 | 0.03 | 0.09 | 0.02 | 0.05 | 0.05 |
| EBITDA | 880.76 Million | 903.73 Million | 2.62 Billion | 401.78 Million | - | 1.34 Billion |
| Earnings Before Tax Margin | 0.04 | 0.04 | 0.11 | 0.02 | 0.07 | 0.07 |
BNB
002038
BTCY
LSCG
DAVANGERE
000607